CHEBI:195521 - leucettine L41

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name leucettine L41
ChEBI ID CHEBI:195521
Definition A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a (2-anilino-5-oxo-1,5-dihydro-4H-imidazol-4-ylidene)methyl group at position 5. It is an inhibitor of DYRK1A, DYRK2, CLK1, and CLK3 (IC50s = 0.04, 0.035, 0.015, and 4.5 μM, respectively).
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Doug Howe
Supplier Information
Download Molfile XML SDF
Formula C17H13N3O3
Net Charge 0
Average Mass 307.309
Monoisotopic Mass 307.09569
InChI InChI=1S/C17H13N3O3/c21-16-13(8-11-6-7-14-15(9-11)23-10-22-14)19-17(20-16)18-12-4-2-1-3-5-12/h1-9H,10H2,(H2,18,19,20,21)/b13-8-
InChIKey PGPHHJBZEGSUNE-JYRVWZFOSA-N
SMILES O=C1NC(NC2=CC=CC=C2)=N\C1=C/C1=CC2=C(OCO2)C=C1
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Biological Role(s): autophagy inducer
Any compound that induces the process of autophagy (the self-digestion of one or more components of a cell through the action of enzymes originating within the same cell).
EC 2.7.12.1 (dual-specificity kinase) inhibitor
An EC 2.7.12.* [dual-specificity kinases (those acting on Ser/Thr and Tyr residues)] inhibitor that inhibits the action of dual-specificity kinase (EC 2.7.12.1).
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of cyclin-dependent kinase (EC 2.7.11.22).
Application(s): nootropic agent
Any compound that improves mental functions such as cognition, memory, intelligence, motivation, attention, and concentration.
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing leucettine L41 (CHEBI:195521) has role autophagy inducer (CHEBI:138880)
leucettine L41 (CHEBI:195521) has role EC 2.7.11.22 (cyclin-dependent kinase) inhibitor (CHEBI:82665)
leucettine L41 (CHEBI:195521) has role EC 2.7.12.1 (dual-specificity kinase) inhibitor (CHEBI:195525)
leucettine L41 (CHEBI:195521) has role neuroprotective agent (CHEBI:63726)
leucettine L41 (CHEBI:195521) has role nootropic agent (CHEBI:66980)
leucettine L41 (CHEBI:195521) is a benzodioxoles (CHEBI:38298)
leucettine L41 (CHEBI:195521) is a imidazolone (CHEBI:20432)
leucettine L41 (CHEBI:195521) is a substituted aniline (CHEBI:48975)
IUPAC Name
(5Z)-2-anilino-5-(1,3-benzodioxol-5-ylmethylidene)-3,5-dihydro-4H-imidazol-4-one
Registry Number Type Source
1112978-84-3 CAS Registry Number ChEBI
Citations Waiting for Citations Types Sources
21615147 PubMed citation Europe PMC
22998443 PubMed citation Europe PMC
23454515 PubMed citation Europe PMC
24366666 PubMed citation Europe PMC
25264830 PubMed citation Europe PMC
26381812 PubMed citation Europe PMC
30115750 PubMed citation Europe PMC
30885273 PubMed citation Europe PMC
31861110 PubMed citation Europe PMC
34090874 PubMed citation SUBMITTER
35841249 PubMed citation Europe PMC
37195917 PubMed citation Europe PMC
Last Modified
04 August 2023